Assessing the Cardiovascular Risk Between Celecoxib and Nonselective Nonsteroidal Antiinflammatory Drugs in Patients With Rheumatoid Arthritis and Osteoarthritis-Reference-Cited by-同舟云学术

Assessing the Cardiovascular Risk Between Celecoxib and Nonselective Nonsteroidal Antiinflammatory Drugs in Patients With Rheumatoid Arthritis and Osteoarthritis

Published:2014 Issue:1 Volume:78 Page:194-205
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hirayama Atsushi¹,Tanahashi Norio²,Daida Hiroyuki³,Ishiguro Naoki⁴,Chachin Motohiko⁵,Sugioka Toshihiko⁶,Kawai Shinichi⁷,on behalf of all ACCEPT study investigators in Japan

Affiliation:

1. Division of Cardiology, Nihon University School of Medicine

2. Department of Neurology, Saitama Medical University, International Medical Center

3. Department of Cardiovascular Medicine, Juntendo University

4. Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine

5. Medical Affairs, Pfizer Japan Inc

6. Medical Affairs, Astellas Pharma Inc

7. Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/1/78_CJ-12-1573/_pdf

Reference35 articles.

1. 1. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012; 64: 455–474.

2. 2. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145–1155.

3. 3. National Institute for Health and Clinical Excellence. Osteoarthritis: The care and management of osteoarthritis in adults. NICE clinical guideline 59. Available at: http://www.nice.org.uk/nicemedia/live/11926/39557/39557.pdf (accessed March 15, 2012).

4. 4. National Institute for Health and Clinical Excellence. Rhematoid arthritis: The management of rheumatoid arthritis in adults. NICE clinical guideline 79. Available at: http://www.nice.org.uk/nicemedia/pdf/CG79NICEGuideline.pdf (accessed March 15, 2012).

5. 5. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669–681.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges for therapy of comorbid patients: a new look at celecoxib. A review;Terapevticheskii arkhiv;2024-06-03

2. The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review;Pain and Therapy;2023-04-24

3. Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System;International Journal of Environmental Research and Public Health;2022-03-16

4. Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis;PLOS ONE;2021-12-21

5. Gene expression profiling of brain endothelial cells after experimental subarachnoid haemorrhage;Scientific Reports;2021-04-09